Search research articles
Contact Us
Filters
Showing results (291-300 of 383) with videos related to
Page
of 39
Sort By:
Endocrine-Related Cancer
|
December 6, 2019
Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response
Laura Valerio, Valeria Bottici, Antonio Matrone, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 30, 2013
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up
Eleonora Molinaro, Carlotta Giani, Laura Agate, et al.
Obesity (Silver Spring, Md.)
|
September 5, 2015
Assessing FOXO1A as a potential susceptibility locus for type 2 diabetes and obesity in American Indians
Yunhua L Muller, Robert L Hanson, Gregory Wiessner, et al.
The American Journal of Cardiology
|
August 9, 2015
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation
Gianluca Di Bella, Fabio Minutoli, Paolo Piaggi, et al.
Endocrine-Related Cancer
|
April 12, 2023
Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis
Nicola Viola, Laura Agate, Sonia Caprio, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 18, 2012
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction
Roberto Rocchi, Riccardo Lenzi, Michele Marinò, et al.
Frontiers in Endocrinology
|
July 24, 2023
Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
Laura Pierotti, Elena Pardi, Elisa Dinoi, et al.
Surgery
|
August 25, 2014
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro
Silvia Martina Ferrari, Poupak Fallahi, Concettina La Motta, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture
Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, et al.
Endocrine-Related Cancer
|
September 17, 2009
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists
Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 383) with videos related to
Sort By:
Page
of 39
Endocrine-Related Cancer
|
December 6, 2019
Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response
Laura Valerio, Valeria Bottici, Antonio Matrone, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 30, 2013
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up
Eleonora Molinaro, Carlotta Giani, Laura Agate, et al.
Obesity (Silver Spring, Md.)
|
September 5, 2015
Assessing FOXO1A as a potential susceptibility locus for type 2 diabetes and obesity in American Indians
Yunhua L Muller, Robert L Hanson, Gregory Wiessner, et al.
The American Journal of Cardiology
|
August 9, 2015
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation
Gianluca Di Bella, Fabio Minutoli, Paolo Piaggi, et al.
Endocrine-Related Cancer
|
April 12, 2023
Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis
Nicola Viola, Laura Agate, Sonia Caprio, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 18, 2012
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction
Roberto Rocchi, Riccardo Lenzi, Michele Marinò, et al.
Frontiers in Endocrinology
|
July 24, 2023
Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
Laura Pierotti, Elena Pardi, Elisa Dinoi, et al.
Surgery
|
August 25, 2014
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro
Silvia Martina Ferrari, Poupak Fallahi, Concettina La Motta, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture
Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, et al.
Endocrine-Related Cancer
|
September 17, 2009
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists
Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Page
of 39